Verdijk P, van der Plas JL, van Brummelen EMJ, Jeeninga RE, et al. First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial. Vaccine 2020 Jul 25. pii: S0264-410X(20)30947.
PMID: 32718816